Transcription of Colorectal Cancer Screening Tests (NCD 210.3)
{{id}} {{{paragraph}}}
Example: air traffic controller
Colorectal Cancer Screening Tests (NCD 210.3)
Colorectal Cancer Screening Tests (NCD ) Page 1 of 7 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/13/2021 Proprietary Information of UnitedHealthcare. Copyright 2021 United HealthCare Services, Inc. UnitedHealthcare Medicare Advantage Policy Guideline Colorectal Cancer Screening Tests (NCD ) Guideline Number: Approval Date: October 13, 2021 Terms and Conditions Table of Contents Page Policy Summary .. 1 Applicable Codes .. 3 References .. 4 Guideline History/Revision Information .. 5 Purpose .. 6 Terms and Conditions .. 6 Policy Summary See Purpose Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service. Item/Service Description General Sections 1861(s)(2)(R) and 1861(pp) of the Social Security Act (the Act) and regulations at 42 CFR authorize Medicare coverage for Screening Colorectal Cancer Tests under Medicare Part B.
adenomatous polyps, familial adenomatous polyposis, or hereditary nonpolyposis colorectal cancer). The blood-based biomarker screening test must have all of the following: Food and Drug Administration (FDA) market authorization with an indication for …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
CANCER SCREENING GUIDELINES, Colorectal cancer, Hereditary nonpolyposis colorectal cancer, Cancer, Legal and Regulatory Services Branch, Hereditary non-polyposis colorectal cancer, Colorectal Cancer Early Detection, Diagnosis, and Staging, Hereditary colorectal cancer, Polyposis, Hereditary Non, Colorectal Cancer Causes, Risk Factors, and Prevention, Colorectal, Hereditary, Blueprint, American Board of Internal